What is NaProTECHNOLOGY®?

NaProTECHNOLOGY® or (Natural Procreative Technology-NaPro) is the result of over 30 years of research by Thomas Hilgers, M.D., an obstetrician/gynecologist at the National Center for Women’s Health in Omaha, Nebraska. This state-of-the-art science has empowered thousands of women throughout the U.S. and around the globe to learn more about their bodies and reproductive health. NaPro provides the best in current medical care, applying diagnostic and therapeutic techniques in a way that is cooperative with the natural functions of a woman’s body. It can be used to treat a wide range of gynecologic problems including premenstrual tension syndrome, ovarian cysts, abnormal bleeding, irregular cycles and recurrent miscarriages.

Through a system called NaProTRACKING, a woman can chart her fertility signs to create a medical record. The process of diagnosis and treatment involves an ongoing dialogue between the woman and her physician, so that the cause of the difficulty can be identified and treated. Through this active participation in her healthcare, a woman becomes empowered to actively collaborate in her treatment. This approach seeks to find the cause for the disease and treat it, rather than suppress the woman’s natural cycle. Many seek the use of NaPro as an alternative to treatment using the birth control pill and others simply want to learn about their fertility.

We at the Vitae Clinic are called to a higher standard of care for our patients in all aspects of obstetrics, infertility, and gynecology with respect and value of life.

We are able to serve the needs of women through NaProTECHNOLOGY® and natural family planning, the method that was developed through extensive research at the National Center for Women’s Health. Since its creation in 1976, NaProTECHNOLOGY® has helped thousands of women and couples. The successes of these innovations have inspired us to create a clinic where we can provide top tier health care while staying true to ethical and religious directives (ERDs). Therefore, we do not provide oral or other artificial contraceptives, provide or refer for abortions or use methods of achieving pregnancy that contradict these directives.

Treating Infertility

Couples who are having difficulty achieving pregnancy want to know the causes for infertility. Surprisingly, many couples are not given the reason as to why they cannot conceive. NaProTECHNOLOGY® takes a natural and cooperative approach to the treatment of infertility, while providing an accurate diagnosis and treatment. NaProTECHNOLOGY®:

  • Helps assess the underlying causes of the reproductive abnormality.
  • Allows for the treatment of these underlying causes.
  • Assists couples in achieving pregnancy while maintaining the natural acts of procreation.

NaProTECHNOLOGY® has been proven to be highly effective in the treatment of infertility due to Endometriosis and Polycystic Ovarian Disease as well as other hormonal disorders and premature birth. It is more effective than and often times less costly than IVF.

“Per Woman” Pregnancy and Family Building Rates
NaProTECHNOLOGY® and IVF

Anovulation NaPro
81.8%
Family Building NaPro `{`<.0001`}`
74.6%
PCOD NaPro `{`<.0001`}`
62.5%
Endo-metriosis NaPro `{`<.0001`}`
56.7%
Tubal Occlusion NaPro `{`<.0216`}`
38.4%
IVF Tubal Occlusion 1986 (Guzick)
27.2%
IVF General 1986 (Guzick)
26.6%
IVF General 2001 (Hogan)
25.6%
IVF General <2 ET 2002 (Sharma)
23.5%
IVF Endo-metriosis 1986 (Guzick)
21.2%

Effectiveness for Infertility Treatment

NaProTECHNOLOGY® has been proven to be highly effective in the treatment of infertility due to Endometriosis and Polycystic Ovarian Disease as well as other hormonal disorders and premature birth.

At right, a life table comparison is shown of the effectiveness of NaProTECHNOLOGY® (in blue) with a similar non-NaProTECHNOLOGY® approach taken at Johns Hopkins University. The success rates are clearly better using the NaProTECHNOLOGY® approach.

[Figure 51-5, p. 682 from the textbook, “The Medical & Surgical Practice of NaProTECHNOLOGY®”. Cumulative pregnancy rate of patients with endometriosis treated with NaProTECHNOLOGY® compared to conservative surgery only. Patients with normospermic husbands only (From: Pope Paul VI Institute research, 2004 and Rock JA, Guzick DS, Sengos C, et al: The Conservative Surgical Treatment of Endometriosis: Evaluation of Pregnancy Success with Respect to the Extent of Disease as Categorized Using Contemporary Classification Systems. Fertil Steril 35:131-137, 1981).]

This study shows the success of NaProTECHNOLOGY® treatment for women with Polycystic Ovarian Disease, compared with surgery only to treat this condition:

[Figure 51-13, p. 683 from the NaProTECHNOLOGY® textbook. Cumulative pregnancy rate for patients with polycystic ovarian disease treated with NaProTECHNOLOGY® compared to surgical wedge resection only. (From: Pope Paul VI Institute research, 2004 and Adashi EY, Rock JA, Guzick D, et al: Fertility Following Bilateral Ovarian Wedge Resection: A Critical Analysis of 90 Consecutive Cases of the Polycystic Ovary Syndrome. Fertil Steril 36:320-325, 1981).]

Terms of Use, Copyright 2006, Pope Paul VI Institute for the Study of Human Reproduction. All rights reserved. *”NaProTECHNOLOGY®” is a registered trademark of the Pope Paul VI Institute for the Study of Human Reproduction. It can be freely used by any person or entity so long as its use reflects the medical concepts and values expressed in the textbook, “The Medical & Surgical Practice of NaProTECHNOLOGY®”.